MSF Science Portal
My saved items
Conference Material > Video
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
Yatskevich N
Share
Linked Items
Share
Video
Countries
Belarus
Subject Area
antibiotic resistance
tuberculosis
antimicrobial resistance
DOI
10.57740/7dx0-kq64
Published Date
07-Jun-2023
Languages
English
Conference
MSF Scientific Day International 2023
Linked Items
Conference Material > Slide Presentation
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
07-Jun-2023
Conference Material > Abstract
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
07-Jun-2023
